MarketResearchNest.com adds “Global Actinic Keratosis Drugs Market 2017-2021” new report to its
research database. The report spread across 80 pages with table and figures in
it.
Research
analysts forecast the global actinic keratosis drugs market to grow at a
CAGR of 3.32% during the period 2017-2021.
About Actinic Keratosis Drugs
Actinic keratosis is a pre-stage non-melanoma skin cancer
caused by exposure to ultraviolet (UV) rays. Initially, the skin has a
sandpaper-like texture with lesions. It can develop into squamous cell
carcinoma, if not treated. The actinic keratosis drugs market includes
nucleoside metabolic inhibitors, photosensitizers, nonsteroidal
anti-inflammatory drugs (NSAIDs), and immunomodulators.
Covered in this report
The report covers the present scenario and the growth
prospects of the global actinic keratosis drugs market for 2017-2021. The
report presents a detailed picture of the market by way of study, synthesis,
and summation of data from multiple sources.
Browse full table of contents and
data tables at https://www.marketresearchnest.com/global-actinic-keratosis-drugs-market-2017-2021.html
The market is divided into the following segments based
on geography:
Americas
APAC
EMEA
Technavio's report, Global Actinic Keratosis Drugs Market
2017-2021, has been prepared based on an in-depth market analysis with inputs
from industry experts. The report covers the market landscape and its growth
prospects over the coming years. The report also includes a discussion of the
key vendors operating in this market.
Technavio recognizes the following companies as the key
players in the global actinic keratosis drugs market: Almirall, GALDERMA, LEO
Pharma, and Valeant.
Other Prominent Vendors in the market are: Biofrontera,
Novartis, Perrigo, Promius Pharma, Taro Pharmaceutical Industries, TOLMAR
Pharmaceuticals, and Vidac Pharma.
Commenting on the report, an analyst from Research team
said: “One trend in the market is novel drug delivery mechanisms. The advent of
novel drug delivery systems such as microneedles will improve the efficacy and
bioavailability of the already marketed formulations. Microneedling has evolved
as an adjuvant therapy to the drug treatment available for actinic keratosis.”
Order a Purchase Report Copy at
https://www.marketresearchnest.com/purchase.php?reportid=280832
According to the report, one driver in the market is high
prevalence of actinic keratosis. Actinic keratosis develops mainly due to UV
exposure. The lesions arising from actinic keratosis can lead to squamous cell
carcinoma if left untreated. With the growing awareness of oncology, people
believe in choosing causative treatment. This leads to a higher incidence rate
of actinic keratosis treatment, which has been driving the market growth. The
prevalence is high in individuals with fair skin and in regions with high
exposure to the sun such as those near the equator. As per the NIH, the
prevalence rate of actinic keratosis was estimated to be 40%-50% in the
Caucasian population aged above 40 years.
Further, the report states that one challenge in the
market is alternative treatment options. The availability of better alternative
treatment modalities is the biggest challenge for the global actinic keratosis
drugs market. The treatment of actinic keratosis through techniques such as
cryotherapy and chemical peeling is more popular than treatment through drugs
due to their better efficacy. Cryotherapy freezes the cells affected by actinic
keratosis by applying liquid nitrogen to the area and thereby stops the disease
growth. Considering that such quick therapies save on time and are convenient
for patients, their popularity is only expected to grow over time.
The study was conducted using an objective combination of
primary and secondary information including inputs from key participants in the
industry. The report contains a comprehensive market and vendor landscape in
addition to a SWOT analysis of the key vendors.
Enquiry before
Buying at https://www.marketresearchnest.com/enquirybuy.php?reportid=280832
About:
MarketResearchNest.com is
the most comprehensive collection of market research products and services on
the Web. We offer reports from almost all top publishers and update our
collection on daily basis to provide you with instant online access to the
world’s most complete and recent database of expert insights on industries,
organizations, products, and trends.
Contact
Mr. Jeet Jain
Sales Manager
+1-240-284-8070(U.S)
+44-20-3290-4151(U.K)
Connect with us: Google+ | LinkedIn | Twitter | Facebook
